San Francisco: 3D Printing and Bioprinting the Heart đź—“

Event

A group of experts from medicine/surgery, regenerative medicine, and entrepreneurs shares their works and insights.

About this Event:

A group of experts from medicine/surgery, regenerative medicine, and entrepreneurs shares their works and insights on how 3D printing and bioprinting is revolutionizing cardiac care.

Agenda:

Date And Time:

Thu, September 26, 2019

6:30 PM – 9:30 PM PDT

Add to Calendar

Location:

McDermott Will & Emery SF Office/Salesforce Building

415 Mission Street Suite 5600 

San Francisco, CA 94105 

United States 

View Map

Agenda:

6:30-7:00 PM Networking/Registration

7:00-7:10 PM Sponsor (MWE) and 3DHEALS Intro

7:10-7:20 PM Dr. Shafkat Anwar  (UCSF)

7:20-7:25 PM Q&A

7:25-7:35 PM Shannon Walters (Stanford)

7:35-7:40 PM Q&A

7:40-7:50 PM Orquidea (Orchid) Garcia (JNJ)

7:50-7:55 PM Q&A

7:55-8:05 Jordan Miller (CEO, Volumetric Biotechnologies)

8:05-8:10 PM Q&A

8:10-8:20 Mike Graffeo (Fluidform3D)

8:20-8:25 PM Q&A

8:25-8:40 Panel Q&A

8:40- 9:30 PM Networking/Wrap up

Speakers:

Shafkat Anwar, MD

Dr. Shafkat Anwar is a pediatric cardiologist with a specialty in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI). Dr. Shafkat Anwar is a pediatric cardiologist with a specialty in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI).

He is the Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). He is a founding member and the inaugural Chair of the Advanced 3D+ Visualization Special Interest Group in the Society for Cardiovascular Magnetic Resonance. He is a consultant at Printerprezz, a medical start-up in Fremont, CA utilizing additive and other advanced manufacturing technologies to develop the next generation of medical devices.  At Printerprezz Dr. Anwar serves as the Senior Vice President of Medical Innovations. Dr. Anwar completed his internship and residency in Pediatrics at Children’s National Medical Center, as well as a research fellowship at the National Institutes of Health. He completed fellowships in Pediatric Cardiology and Cardiac Imaging at Cleveland Clinic and Children’s Hospital of Philadelphia. Prior to joining UCSF, Dr. Anwar was Cardiology Director of Cardiac MRI at Washington University in St. Louis, St. Louis Children’s Hospital.  At Wash. U. Dr. Anwar co-founded and co-directed the Center for 3D Printing, a multi-disciplinary 3D printing center.

Cardiac 3D Printing: The Heart of the Matter

The Heart of the Matter: Interview with Dr. Shafkat Anwar, UCSF


Shannon Walters, MS RT(MR), Stanford University Department of Radiology, 3D and Quantitative Imaging Laboratory

Shannon Walters is an innovation enabler and workflow, optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time.

Interview: Shannon Walters, Executive Manager @ Stanford 3D and Quantitative Imaging Lab

Segmentation: The Real Struggles Behind Converting DICOM to Patient-specific 3D Printable Models


Orquidea (Orchid) Garcia

As a Johnson & Johnson Research Fellow and Lead for 3D Bioprinting and Tissue Regen Technologies, Orquidea (Orchid) Garcia is the technical lead for 3D bioprinting, and related tissue regen technology development. She is responsible for the evaluation and execution of technical strategies and new technologies integration to develop a new class of next-generation healthcare solutions. Orchid works closely with internal business partners, as well as technology, academia and government partners to develop the CoE’s bioprinting capabilities.    

Orchid has extensive experience identifying novel technologies through scientific discovery and translating them into patentable, marketable technologies both in industry and academia. Having served as the scientific subject matter expert on numerous initiatives, she brings a keen understanding of world-wide technical, scientific, regulatory and policy issues that face the business. 

Previously, Orchid held various positions at J&J in Clinical Affairs and Regulatory Affairs. She received a Bachelor of Science degree in Biochemistry and Cellular Biology from the University of California San Diego; a Master of Science degree in Microbiology from California State University Los Angeles; and a PhD in Medical Biology from the University of Southern California, Keck School of Medicine. She is a Fellow of the California Institute of Regenerative Medicine (CIRM). Orchid is based in Irvine, CA.

Believe in Your Science: Interview with Dr. Orquidea (Orchid) Garcia, Johnson & Johnson


MIKE GRAFFEO, CEO, Fluidform3D

A senior executive with a proven track record in commercialization of innovative medical technology, Mike is a results-oriented, decisive leader with a track record of successfully growing new businesses in both startup and growth organizations. Throughout his career, he has gained extensive experience translating highly complex devices and clinical data into successful businesses, both in the US and globally. Mike holds a BS in Engineering Physics and an MEng in Mechanical Engineering from Cornell University, as well as an MBA from Harvard Business School.

Bioprint Heart Components: Interview with Fluidform3D CEO Mike Graffeo


Jordan Miller is an Assistant Professor of Bioengineering at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his PhD in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.

Engineering Vasculatures: Interview with Dr. Jordan Miller, Volumetric


Organizers:

Roger Kuan

Roger Kuan focuses his practice on intellectual property (IP) procurement/portfolio management, IP transactions and strategic IP counseling for life sciences clients (e.g., research tools, analytical instrumentation/software, medical devices, diagnostics, biomanufacturing systems, etc.) with a focus in emerging technologies such as digital health (e.g., mobile apps, clinical decision support software, digital therapeutics, AI/ML imaging diagnostics, etc.), personalized medicine (e.g., genomic sequencing platforms, AI/ML computational genomics/bioinformatics, molecular diagnostics, etc.) and 3D printing/bioprinting. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution. He served as Director IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Patent Protection for Medical 3D Printing & Bioprinting Technologies


Jenny Chen/ 3D Heals

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS, a company focusing on curating healthcare 3D printing ecosystem. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Pricing Strategies for 3D Printed or 3D Printing Related Medical Devices

Healthcare 3D Printing Clinical Trials

Road to Reimbursements for 3D Printed Anatomical Models and Surgical Guides – Decoding the CPT Codes

Sponsor:


Want to be our sponsor? Email to: [email protected]

Comments